# Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea

> **NCT02015637** · PHASE3 · TERMINATED · sponsor: **Melinta Therapeutics, Inc.** · enrollment: 460 (actual)

## Conditions studied

- Gonorrhea

## Interventions

- **DRUG:** Delafloxacin
- **DRUG:** Ceftriaxone

## Key facts

- **NCT ID:** NCT02015637
- **Lead sponsor:** Melinta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-01-23
- **Primary completion:** 2014-11
- **Final completion:** 2014-12-10
- **Target enrollment:** 460 (ACTUAL)
- **Last updated:** 2018-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02015637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02015637, "Comparison of Delafloxacin Versus Ceftriaxone for the Treatment of Uncomplicated Gonorrhea". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02015637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*